Adipose-derived mesenchymal stem cells (Ad-MSCs) have been designated as the
promising agents for clinical applications for easy accessibility, multi-linage differentiation …

The homing properties of adipose tissue-derived mesenchymal stem cells (AdMSCs) have
stimulated intravenous applications for their use in stem cell therapy. However, the soluble …

Mesenchymal stem cells (MSCs) have drawn great attention because of their therapeutic
potential. It has been suggested that intra‐venous infused MSCs could migrate the site of …

Clinical applications of mesenchymal stem cells (MSCs) rely on their capacity to home and
engraft in the appropriate target injury tissues for the long term. However, their homing …

Hypoxic conditions have been reported to facilitate preservation of undifferentiated
mesenchymal stem cell (MSC) phenotype and positively affect their colony-forming potential …

Hypoxia‐mimetic agents are new potential tools in MSC priming instead of hypoxia
incubators or chambers. Several pharmaceutical/chemical hypoxia‐mimetic agents can be …

Objective (s): The limited homing potential of bone-marrow-derived mesenchymal stem cells
(BM-MSC) is the key obstacle in MSC-based therapy. It is believed that chemokines and …

Mobilization of mesenchymal stem cells (MSCs) is a promising strategy for tissue repair and
regenerative medicine. The establishment of an appropriate animal model and clarification …

Objectives Cell migration is necessary for numerous physiological cell processes. Although
either inflammatory or hypoxic stimuli of certain dose and duration have positive influence …

Abstract Background Mesenchymal stem cells (MSCs) derived from bone marrow have
potent stabilizing effects for the treatment of acute respiratory distress syndrome (ARDS) …